|Mr. Peter J. Davey MBA, GradDip Bus., Dip.Art, GAICD||CEO, MD & Exec. Director||564.14k||N/A||N/A|
|Mr. Paul A. Sherman B.Bus, CA, MBA||CFO & Company Sec.||238.25k||N/A||N/A|
|Mr. D. Pierotti||Operations Mang.||N/A||N/A||N/A|
|Dr. C. Patch||Chief Innovation Officer||N/A||N/A||N/A|
|S. Poothong||Chief Commercial Officer||N/A||N/A||N/A|
Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. The company is also involved in the production of encapsulated powders; and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milk products, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. The company was founded in 1988 and is headquartered in Westmeadows, Australia.
Clover Corporation Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.